拮抗剂-话题@MedSci

#拮抗剂#

223篇内容 | 4497人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1511701, encodeId=2b641511e0119, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Diabetologia：GIP(3-30)NH2是一种有效的GIP受体拮抗剂?, objectType=article, longId=136354, objectId=543d13635421, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=543d13635421, replyNumber=0, likeNumber=72, createdTime=2018-04-26, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=543d13635421, moduleTitle=Diabetologia：GIP(3-30)NH2是一种有效的GIP受体拮抗剂?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=543d13635421)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511700, encodeId=b6e21511e00cf, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Liver Int：盐皮质激素受体拮抗剂—Eplerenone意外地显著增加了HIV患者肝脏脂肪含量, objectType=article, longId=133897, objectId=097513389e59, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=097513389e59, replyNumber=0, likeNumber=63, createdTime=2018-04-01, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=097513389e59, moduleTitle=Liver Int：盐皮质激素受体拮抗剂—Eplerenone意外地显著增加了HIV患者肝脏脂肪含量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=097513389e59)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511699, encodeId=09fd15116992a, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=口服型CGRP受体拮抗剂rimegepant的晚期临床研究取得成功, objectType=article, longId=133728, objectId=25d6133e2817, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25d6133e2817, replyNumber=0, likeNumber=59, createdTime=2018-03-30, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25d6133e2817, moduleTitle=口服型CGRP受体拮抗剂rimegepant的晚期临床研究取得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25d6133e2817)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511698, encodeId=73641511698dc, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=2018 EHRA实践指导：房颤患者应用非维生素K拮抗剂口服抗凝药, objectType=article, longId=133677, objectId=93201336e738, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93201336e738, replyNumber=0, likeNumber=28, createdTime=2018-03-29, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93201336e738, moduleTitle=2018 EHRA实践指导：房颤患者应用非维生素K拮抗剂口服抗凝药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93201336e738)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511697, encodeId=8b86151169eb8, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Stroke：缺血性卒中皮下注射白细胞介素-1受体拮抗剂疗效分析, objectType=article, longId=133244, objectId=8b8a13324461, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b8a13324461, replyNumber=0, likeNumber=62, createdTime=2018-03-25, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b8a13324461, moduleTitle=Stroke：缺血性卒中皮下注射白细胞介素-1受体拮抗剂疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b8a13324461)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511696, encodeId=412615116966b, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Nephrol Dial Transpl：维生素K拮抗剂对肾病透析患者的死亡率有何影响？, objectType=article, longId=131187, objectId=a77a13118efd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a77a13118efd, replyNumber=0, likeNumber=93, createdTime=2018-03-03, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a77a13118efd, moduleTitle=Nephrol Dial Transpl：维生素K拮抗剂对肾病透析患者的死亡率有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a77a13118efd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511695, encodeId=e68c151169569, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=J Am Acad Dermatol：NK1R拮抗剂治疗慢性瘙痒的2期临床试验, objectType=article, longId=131180, objectId=aaf31311809d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaf31311809d, replyNumber=0, likeNumber=67, createdTime=2018-03-03, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaf31311809d, moduleTitle=J Am Acad Dermatol：NK1R拮抗剂治疗慢性瘙痒的2期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaf31311809d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511694, encodeId=0b9315116941a, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=J Clin Periodontol：WNT/β-catenin信号拮抗剂在2型糖尿病和吸烟相关牙周炎中的作用, objectType=article, longId=130567, objectId=f39213056eef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f39213056eef, replyNumber=0, likeNumber=84, createdTime=2018-02-26, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f39213056eef, moduleTitle=J Clin Periodontol：WNT/β-catenin信号拮抗剂在2型糖尿病和吸烟相关牙周炎中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f39213056eef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511693, encodeId=2357151169372, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Lancet Gastroen Hepatol：质子泵抑制剂、前列腺素类似物以及组胺-2受体拮抗剂对预防和治疗消化性溃疡及其并发症的效果研究, objectType=article, longId=130296, objectId=76071302962c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76071302962c, replyNumber=0, likeNumber=0, createdTime=2018-02-24, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76071302962c, moduleTitle=Lancet Gastroen Hepatol：质子泵抑制剂、前列腺素类似物以及组胺-2受体拮抗剂对预防和治疗消化性溃疡及其并发症的效果研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76071302962c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511692, encodeId=8915151169222, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Int J Cardiol：白细胞介素-1受体拮抗剂对冠心病患者预后的影响！, objectType=article, longId=128676, objectId=62991286e686, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62991286e686, replyNumber=0, likeNumber=0, createdTime=2018-02-04, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62991286e686, moduleTitle=Int J Cardiol：白细胞介素-1受体拮抗剂对冠心病患者预后的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62991286e686)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511691, encodeId=bb301511691af, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Am Heart J：盐皮质激素拮抗剂对所有MI患者都有获益？, objectType=article, longId=127581, objectId=1e8312e581ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e8312e581ce, replyNumber=0, likeNumber=61, createdTime=2018-01-26, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e8312e581ce, moduleTitle=Am Heart J：盐皮质激素拮抗剂对所有MI患者都有获益？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e8312e581ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511690, encodeId=c36d1511690c6, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JAMA Intern Med：COPD患者新接受长效β2激动剂或长效M拮抗剂导致心血管疾病风险增加, objectType=article, longId=125387, objectId=a18112538e0b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a18112538e0b, replyNumber=0, likeNumber=53, createdTime=2018-01-05, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a18112538e0b, moduleTitle=JAMA Intern Med：COPD患者新接受长效β2激动剂或长效M拮抗剂导致心血管疾病风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a18112538e0b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511689, encodeId=d676151168976, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=EUR J Cancer：用于实体瘤治疗的全新human double minute 2（HDM2）拮抗剂SAR405838的I期临床研究, objectType=article, longId=124752, objectId=fc20124e5249, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc20124e5249, replyNumber=0, likeNumber=65, createdTime=2017-12-28, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc20124e5249, moduleTitle=EUR J Cancer：用于实体瘤治疗的全新human double minute 2（HDM2）拮抗剂SAR405838的I期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc20124e5249)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511688, encodeId=fb96151168838, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JAHA：盐皮质激素受体拮抗剂可减少心衰患者再住院率, objectType=article, longId=124441, objectId=4bb112444114, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bb112444114, replyNumber=0, likeNumber=73, createdTime=2017-12-25, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bb112444114, moduleTitle=JAHA：盐皮质激素受体拮抗剂可减少心衰患者再住院率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bb112444114)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511687, encodeId=346f151168e1d, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JCO：HIF-2α拮抗剂PT2385治疗晚期透明细胞肾癌, objectType=article, longId=124091, objectId=1eb21240911b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eb21240911b, replyNumber=0, likeNumber=63, createdTime=2017-12-22, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eb21240911b, moduleTitle=JCO：HIF-2α拮抗剂PT2385治疗晚期透明细胞肾癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1eb21240911b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511686, encodeId=4cf2151168680, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=J Thromb Haemost：CYP2C9/VKORC1基因突变影响患者使用VK拮抗剂的结局？, objectType=article, longId=122398, objectId=b49d122398ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b49d122398ef, replyNumber=0, likeNumber=67, createdTime=2017-12-07, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b49d122398ef, moduleTitle=J Thromb Haemost：CYP2C9/VKORC1基因突变影响患者使用VK拮抗剂的结局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b49d122398ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511685, encodeId=1b4e15116859d, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Eur J Clin Pharmacol：非瓣膜性房颤患者初始用药：达比加群还是维生素K拮抗剂？, objectType=article, longId=119554, objectId=379c11955440, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=379c11955440, replyNumber=0, likeNumber=21, createdTime=2017-11-12, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=379c11955440, moduleTitle=Eur J Clin Pharmacol：非瓣膜性房颤患者初始用药：达比加群还是维生素K拮抗剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=379c11955440)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511684, encodeId=0e101511684af, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Eur J Heart Fail：心衰伴射血分数降低患者盐皮质激素受体拮抗剂的使用情况如何？, objectType=article, longId=118580, objectId=7182118580ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7182118580ac, replyNumber=0, likeNumber=56, createdTime=2017-11-04, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7182118580ac, moduleTitle=Eur J Heart Fail：心衰伴射血分数降低患者盐皮质激素受体拮抗剂的使用情况如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7182118580ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511683, encodeId=f321151168372, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Int J Clin Pract:肾功能是否影响使用维生素K拮抗剂的非瓣膜性房颤患者抗凝控制？, objectType=article, longId=117839, objectId=06ed11e83930, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06ed11e83930, replyNumber=0, likeNumber=78, createdTime=2017-10-29, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06ed11e83930, moduleTitle=Int J Clin Pract:肾功能是否影响使用维生素K拮抗剂的非瓣膜性房颤患者抗凝控制？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06ed11e83930)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511682, encodeId=28801511682bc, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Stroke：房颤患者福音——新型口服非维生素K拮抗剂抗凝药, objectType=article, longId=116693, objectId=583c116693ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=583c116693ee, replyNumber=0, likeNumber=45, createdTime=2017-10-20, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=583c116693ee, moduleTitle=Stroke：房颤患者福音——新型口服非维生素K拮抗剂抗凝药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=583c116693ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

拮抗剂

2020-05-29

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Diabetologia：GIP(3-30)NH2是一种有效的GIP受体拮抗剂?

2018-04-26

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Liver Int：盐皮质激素受体拮抗剂—Eplerenone意外地显著增加了HIV患者肝脏脂肪含量

2018-04-01

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

口服型CGRP受体拮抗剂rimegepant的晚期临床研究取得成功

2018-03-30

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

2018 EHRA实践指导：房颤患者应用非维生素K拮抗剂口服抗凝药

2018-03-29

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Stroke：缺血性卒中皮下注射白细胞介素-1受体拮抗剂疗效分析

2018-03-25

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Nephrol Dial Transpl：维生素K拮抗剂对肾病透析患者的死亡率有何影响？

2018-03-03

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

J Am Acad Dermatol：NK1R拮抗剂治疗慢性瘙痒的2期临床试验

2018-03-03

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

J Clin Periodontol：WNT/β-catenin信号拮抗剂在2型糖尿病和吸烟相关牙周炎中的作用

2018-02-26

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Lancet Gastroen Hepatol：质子泵抑制剂、前列腺素类似物以及组胺-2受体拮抗剂对预防和治疗消化性溃疡及其并发症的效果研究

2018-02-24

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Int J Cardiol：白细胞介素-1受体拮抗剂对冠心病患者预后的影响！

2018-02-04

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Am Heart J：盐皮质激素拮抗剂对所有MI患者都有获益？

2018-01-26

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JAMA Intern Med：COPD患者新接受长效β2激动剂或长效M拮抗剂导致心血管疾病风险增加

2018-01-05

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

EUR J Cancer：用于实体瘤治疗的全新human double minute 2（HDM2）拮抗剂SAR405838的I期临床研究

2017-12-28

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JAHA：盐皮质激素受体拮抗剂可减少心衰患者再住院率

2017-12-25

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JCO：HIF-2α拮抗剂PT2385治疗晚期透明细胞肾癌

2017-12-22

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

J Thromb Haemost：CYP2C9/VKORC1基因突变影响患者使用VK拮抗剂的结局？

2017-12-07

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Eur J Clin Pharmacol：非瓣膜性房颤患者初始用药：达比加群还是维生素K拮抗剂？

2017-11-12

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Eur J Heart Fail：心衰伴射血分数降低患者盐皮质激素受体拮抗剂的使用情况如何？

2017-11-04

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Int J Clin Pract:肾功能是否影响使用维生素K拮抗剂的非瓣膜性房颤患者抗凝控制？

2017-10-29

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Stroke：房颤患者福音——新型口服非维生素K拮抗剂抗凝药

2017-10-20

科室
- - 订阅+
  - 更多科室
工具
服务